Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life
I am a curious individual by nature, driven by passion and I translate that into my writings
Wolfgang Marik: declares no conflict of interest relevant to this study
Comprehensive assessments included body weight, 2-D echocardiography, invasive hemodynamics, exercise capacity as well as cardiac and hepatic fibrosis and lipid deposition
Oral semaglutide does not slow the progression of Alzheimer's disease, according to a trial Oral semaglutide is not effective in slowing the progression of the disease in patients with mild Alzheimers disease, according to the findings of the first large-scale, randomised phase 3 clinical trials published in The Lancet
GIPR signaling reduces dopamine release in the brain New work from the lab